Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms FMF-05-178-1 |
Target |
Action inhibitors |
Mechanism BLK inhibitors(BLK proto-oncogene, Src family tyrosine kinase inhibitors), CSK inhibitors(C-terminal Src kinase inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC55H68F3N11O8S |
InChIKeyBXIDSMGAOSLGRK-OESUUHGFSA-N |
CAS Registry- |